List of clinical testing equipment patents

Patent 11397150 was granted and assigned to Otsuka Pharmaceutical Co., Ltd. on July, 2022 by the United States Patent and Trademark Office.

Patent 11529071 was granted and assigned to Otsuka Pharmaceutical Co., Ltd. on December, 2022 by the United States Patent and Trademark Office.

Patent 11353401 was granted and assigned to Otsuka Pharmaceutical Co., Ltd. on June, 2022 by the United States Patent and Trademark Office.

Patent 11630071 was granted and assigned to Otsuka Pharmaceutical Co., Ltd. on April, 2023 by the United States Patent and Trademark Office.

Patent 11565450 was granted and assigned to Otsuka Pharmaceutical Co., Ltd. on January, 2023 by the United States Patent and Trademark Office.

Patent 11648347 was granted and assigned to Otsuka Pharmaceutical Co., Ltd. on May, 2023 by the United States Patent and Trademark Office.

Patent 11366130 was granted and assigned to Otsuka Pharmaceutical Co., Ltd. on June, 2022 by the United States Patent and Trademark Office.

Patent 11549940 was granted and assigned to Otsuka Pharmaceutical Co., Ltd. on January, 2023 by the United States Patent and Trademark Office.

Patent 11504511 was granted and assigned to Otsuka Pharmaceutical Co., Ltd. on November, 2022 by the United States Patent and Trademark Office.

Patent 11638757 was granted and assigned to Otsuka Pharmaceutical Co., Ltd. on May, 2023 by the United States Patent and Trademark Office.

Patent 12117460 was granted and assigned to Otsuka Pharmaceutical Co., Ltd. on October, 2024 by the United States Patent and Trademark Office.

Patent 7053092 was granted and assigned to Otsuka Pharmaceutical Co., Ltd. on May, 2006 by the United States Patent and Trademark Office.

Patent 11464423 was granted and assigned to Otsuka Pharmaceutical Co., Ltd. on October, 2022 by the United States Patent and Trademark Office.

Patent 11564885 was granted and assigned to Otsuka Pharmaceutical Co., Ltd. on January, 2023 by the United States Patent and Trademark Office.

Patent 11534764 was granted and assigned to Otsuka Pharmaceutical Co., Ltd. on December, 2022 by the United States Patent and Trademark Office.

Patent 11358311 was granted and assigned to Otsuka Pharmaceutical Co., Ltd. on June, 2022 by the United States Patent and Trademark Office.

Patent 11412770 was granted and assigned to Otsuka Pharmaceutical Co., Ltd. on August, 2022 by the United States Patent and Trademark Office.

Patent D518381 was granted and assigned to Otsuka Pharmaceutical Co., Ltd. on April, 2006 by the United States Patent and Trademark Office.

Patent 11414391 was granted and assigned to Otsuka Pharmaceutical Co., Ltd. on August, 2022 by the United States Patent and Trademark Office.

Patent 7026486 was granted and assigned to Otsuka Pharmaceutical Co., Ltd. on April, 2006 by the United States Patent and Trademark Office.